Dabur Research Foundation
Manu Jaggi currently serves as the Chief Operating Officer at Dabur Research Foundation, a position held since July 2018, after previously acting as Chief Scientific Officer for both Dabur Research Foundation and Althea Lifesciences from July 2014 to July 2018. With a robust background in research and development, Manu has led a team of approximately 80 scientists in the preclinical domain, focusing on business development and strategic partnerships across global markets, including the US, EU, and APAC. Previous roles include Vice President (R&D), Director - R&D, and Head of Preclinical Research at Dabur Research Foundation from 1994 to 2014. Manu holds a Ph.D. in Tumor Biology from the National Institute of Immunology and an M.Pharm in Pharmaceutics from Delhi University.
This person is not in any teams
Dabur Research Foundation
Dabur Research Foundation (DRF) is an Indian Contract Research Organization Est.1979 offering preclinical services in Drug Discovery and Development, ranging from identification of potential lead molecules, drug development to IND enabling studies. We offer preclinical services to global Biotech, Pharma, Phytopharmaceuticals Cosmeceuticals and academia sectors. Our services broadly fall into the functional areas of In Vitro, Ex-Vivo & In Vivo Pharmacology, Exploratory & GLP Toxicology & DMPK. Our genesis is from the Dabur group of companies; we started operating as a preclinical service provider after a strategy spin-off from our parent company in the year 2008. It is this experience of 30 years of drug discovery & development that we bring to our clients as a preclinical service provider.